Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Credit agrmnt [a]
Director departure
Inv. presentation
Quarterly results
Acq. announced

PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/19/2019 GN Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management
11/13/2018 GN Detailed Research: Economic Perspectives on Pernix Therapeutics, Hallador Energy, Vince Holding, Tuesday Morning, Information Services Group, and Sienna Biopharmaceuticals — What Drives Growth in Today's Competitive Landscape
11/02/2018 GN Pernix Therapeutics to Report Third Quarter 2018 Financial Results on Thursday, November 8
09/12/2018 GN Pernix Therapeutics Holdings, Inc.'s Subsidiaries File Notice of Appeal in Patent Litigation Concerning Zohydro® ER with BeadTek®
08/27/2018 GN Pernix Therapeutics Announces Ruling in Patent Litigation Concerning Zohydro® ER with BeadTek®
08/09/2018 GN Pernix Therapeutics Reports Second Quarter 2018 Financial Results
08/01/2018 GN Pernix Therapeutics Announces a Series of Transactions to Strengthen Its Balance Sheet and Improve Financial Flexibility
07/31/2018 GN Pernix Therapeutics to Report Second Quarter 2018 Financial Results on Thursday, August 9

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy